Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	regulation of organelle organization	TBC1D8 TPR RBSN LIMA1 MAP1A CENPF PRKAA1 SEC16A ARFGEF1 AKAP13 GCH1 PIWIL2 DELE1 ATM HAX1 KANK2 PHIP ZEB2 C2CD5	4.19e-07	1342	78	19	GO:0033043
GeneOntologyBiologicalProcess	regulation of mRNA export from nucleus	TPR THOC2 IWS1	8.40e-06	11	78	3	GO:0010793
GeneOntologyBiologicalProcess	regulation of ribonucleoprotein complex localization	TPR THOC2 IWS1	1.45e-05	13	78	3	GO:2000197
GeneOntologyBiologicalProcess	ribonucleoprotein complex localization	TPR THOC2 IWS1	1.84e-05	14	78	3	GO:0071166
GeneOntologyBiologicalProcess	regulation of RNA export from nucleus	TPR THOC2 IWS1	3.41e-05	17	78	3	GO:0046831
GeneOntologyBiologicalProcess	regulation of nucleobase-containing compound transport	TPR THOC2 IWS1	5.66e-05	20	78	3	GO:0032239
Domain	Post-SET_dom	KMT2C ASH1L	2.14e-03	16	81	2	IPR003616
Domain	PostSET	KMT2C ASH1L	2.14e-03	16	81	2	SM00508
Domain	POST_SET	KMT2C ASH1L	2.14e-03	16	81	2	PS50868
Domain	Ser/Thr_kinase_AS	PIM3 BMPR2 PRKAA1 NEK9 MAP4K2 MAP3K5	4.56e-03	357	81	6	IPR008271
Domain	PROTEIN_KINASE_ST	PIM3 BMPR2 PRKAA1 NEK9 MAP4K2 MAP3K5	4.87e-03	362	81	6	PS00108
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	ZNF8 TPR RBSN CENPF ZC3H13 SEC16A NAV2 AKAP13 THOC2 ANKLE2 IWS1	2.89e-08	503	82	11	16964243
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TPR KMT2C PPRC1 ZC3H13 PRKAA1 ASH1L SEC16A CHD2 THOC2 ANKLE2 GOLGB1 C2CD5 COPS7A	1.48e-06	1084	82	13	11544199
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ZXDC PIM3 KMT2C CELSR3 PPRC1 PIEZO1 ZNF408 L1CAM SEC16A NAV2 AKAP13 MED13L MAP3K5	1.83e-06	1105	82	13	35748872
Pubmed	A human MAP kinase interactome.	TPR KMT2C MAP1A HPS4 NAV2 AKAP13 LCP2 GOLGB1 MAP3K5	2.24e-06	486	82	9	20936779
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	TPR MISP LIMA1 CENPF SEC16A KANK2 GOLGB1	2.56e-06	256	82	7	33397691
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPR LIMA1 CENPF SPHKAP SEC16A PPP6R2 KANK2 NEK9 ZEB2 GOLGB1 TP53BP2 MAP3K5	2.65e-06	963	82	12	28671696
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	KMT2C CENPF ZNF408 IGHMBP2 NAV2 CHD2 ATM LCP2 COPS7A	2.69e-06	497	82	9	36774506
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	ZNF8 SEC16A MED13L THOC2 KANK2 NEK9 PHIP TP53BP2 FAM111B IWS1	2.89e-06	645	82	10	25281560
Pubmed	Knockdown of AMPKα decreases ATM expression and increases radiosensitivity under hypoxia and nutrient starvation in an SV40-transformed human fibroblast cell line, LM217.	PRKAA1 ATM	5.49e-06	2	82	2	29284117
Pubmed	Activation of AMP-activated protein kinase in cerebella of Atm-/- mice is attributable to accumulation of reactive oxygen species.	PRKAA1 ATM	5.49e-06	2	82	2	22260947
Pubmed	Nuclear DNA damage-triggered ATM-dependent AMPK activation regulates the mitochondrial radiation response.	PRKAA1 ATM	5.49e-06	2	82	2	38166485
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZNF8 TPR CENPF SEC16A NEK9 ZEB2 GOLGB1 TP53BP2	6.68e-06	418	82	8	34709266
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	TBC1D8 MAP1A IQCC DROSHA SEC16A PPP6R2 GOLGB1 FAM111B COPS7A	1.04e-05	588	82	9	38580884
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TBC1D8 MISP MAP1A SEC16A KANK2 TP53BP2	1.05e-05	209	82	6	36779422
Pubmed	BNIP2 extra long inhibits RhoA and cellular transformation by Lbc RhoGEF via its BCH domain.	PRUNE2 AKAP13	1.64e-05	3	82	2	18445682
Pubmed	AMPK increases expression of ATM through transcriptional factor Sp1 and induces radioresistance under severe hypoxia in glioblastoma cell lines.	PRKAA1 ATM	1.64e-05	3	82	2	34973534
Pubmed	Genomic Characterization of Metformin Hepatic Response.	PRKAA1 ATM	1.64e-05	3	82	2	27902686
Pubmed	PI3K-like kinases restrain Pim gene expression in endothelial cells.	PIM3 ATM	1.64e-05	3	82	2	22282239
Pubmed	Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors.	KMT2C NR1H3	1.64e-05	3	82	2	18372346
Pubmed	Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours.	UNC5CL PRKAA1	1.64e-05	3	82	2	26129866
Pubmed	Improved lipid profile through liver-specific knockdown of liver X receptor alpha in KKAy diabetic mice.	ASIP NR1H3	3.28e-05	4	82	2	18769020
Pubmed	Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension.	BMPR2 ATM	3.28e-05	4	82	2	37989727
Pubmed	EEPD1 Is a Novel LXR Target Gene in Macrophages Which Regulates ABCA1 Abundance and Cholesterol Efflux.	EEPD1 NR1H3	3.28e-05	4	82	2	28082258
Pubmed	IGF-1 phosphorylates AMPK-alpha subunit in ATM-dependent and LKB1-independent manner.	PRKAA1 ATM	3.28e-05	4	82	2	15485651
Pubmed	Novel interactors and a role for supervillin in early cytokinesis.	LIMA1 CENPF HAX1	3.97e-05	28	82	3	20309963
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PRUNE2 KMT2C BMPR2 DTNB EEPD1 ASH1L ASTN2 AKAP13 KATNIP CHD2 NEK9 GOLGB1 NPAS2	4.38e-05	1489	82	13	28611215
Pubmed	Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.	DTNB PRKAA1 SEC16A HAX1 NEK9 C2CD5 MAP3K5	4.65e-05	401	82	7	25852190
Pubmed	Extra-toes (Xt) homozygous mutant mice demonstrate a role for the Gli-3 gene in the development of the forebrain.	ASIP L1CAM	5.47e-05	5	82	2	7976186
Pubmed	Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.	ASIP NR1H3	5.47e-05	5	82	2	15146238
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	KMT2C CENPF DROSHA ZC3H13 ZNF408 AKAP13 CHD2 PIWIL2 ATM	6.00e-05	736	82	9	29676528
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF8 TC2N MAP1A DROSHA ASH1L CIAO2B SEC16A HAX1 KANK2 PHIP C2CD5	6.17e-05	1116	82	11	31753913
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	TPR LIMA1 DTNB SEC16A HAX1 PPP6R2 ANKLE2 TP53BP2	6.32e-05	573	82	8	28330616
Pubmed	The Transcription Factor ZEB2 Is Required to Maintain the Tissue-Specific Identities of Macrophages.	NR1H3 ZEB2	8.19e-05	6	82	2	30076102
Pubmed	Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1.	PRKAA1 ATM	8.19e-05	6	82	2	23878245
Pubmed	Dystroglycan is a scaffold for extracellular axon guidance decisions.	CELSR3 L1CAM	8.19e-05	6	82	2	30758284
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	TPR CENPF SEC16A PIPOX NEK9 ZEB2	8.51e-05	304	82	6	32235678
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	LIMA1 DPCD SEC16A THOC2 PPP6R2 TP53BP2 C2CD5	9.04e-05	446	82	7	24255178
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	PPRC1 KATNIP ZEB2 C2CD5	1.14e-04	105	82	4	9628581
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	MISP MAP1A CENPF SEC16A KANK2 TP53BP2 COPS7A	1.28e-04	472	82	7	38943005
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	MISP LIMA1 CENPF PIEZO1 IWS1	1.43e-04	210	82	5	16565220
Pubmed	Tagging genes with cassette-exchange sites.	KMT2C LIMA1 DROSHA NAV2 AKAP13 ANKLE2	1.45e-04	335	82	6	15741177
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	KMT2C ASH1L	1.52e-04	8	82	2	23130995
Pubmed	De novo inbred heterozygous Zeb2/Sip1 mutant mice uniquely generated by germ-line conditional knockout exhibit craniofacial, callosal and behavioral defects associated with Mowat-Wilson syndrome.	L1CAM ZEB2	1.52e-04	8	82	2	26319231
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPR CENPF ZC3H13 SEC16A CHD2 ATM THOC2 PHIP	1.56e-04	653	82	8	22586326
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PRUNE2 EEPD1 ASTN2 DELE1 PPP6R2 NEK9 C2CD5	1.68e-04	493	82	7	15368895
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	RBSN KATNIP PPP6R2 NEK9 TP53BP2	1.70e-04	218	82	5	33378226
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	TPR CENPF KANK2 GOLGB1	1.80e-04	118	82	4	30979931
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RBSN LIMA1 BMPR2 SEC16A NAV2 AKAP13 NEK9 GOLGB1 TP53BP2	1.95e-04	861	82	9	36931259
Pubmed	Early forebrain wiring: genetic dissection using conditional Celsr3 mutant mice.	CELSR3 L1CAM	1.96e-04	9	82	2	18487195
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	PRUNE2 KMT2C SEC16A NAV2 MED13L	1.97e-04	225	82	5	12168954
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CELSR3 PPRC1 DROSHA HPS4 ASH1L CIAO2B ASTN2 ATM MED13L KANK2 ZEB2	2.13e-04	1285	82	11	35914814
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ZNF8 MAP1A DROSHA ZC3H13 CHD2 ATM HAX1 THOC2 IWS1 NPAS2	2.29e-04	1082	82	10	38697112
Pubmed	AMPK modulates Hippo pathway activity to regulate energy homeostasis.	PRKAA1 TP53BP2	2.44e-04	10	82	2	25751139
Pubmed	KSHV Viral Protein Kinase Interacts with USP9X to Modulate the Viral Lifecycle.	SEC16A PPP6R2	2.44e-04	10	82	2	36995092
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	PIM3 PRKAA1 NR1H3 NEK9 MAP4K2 MAP3K5	2.54e-04	372	82	6	22939624
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	DPCD ASH1L CHD2 HAX1 THOC2 PHIP MAP3K5	2.69e-04	533	82	7	30554943
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TPR KMT2C LIMA1 SEC16A THOC2 NEK9 TP53BP2	3.22e-04	549	82	7	38280479
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TPR LIMA1 MAP1A SEC16A THOC2 PPP6R2 NEK9 GOLGB1 TP53BP2	3.55e-04	934	82	9	33916271
Pubmed	Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer.	SPHKAP ASH1L NAV2 GOLGB1 MAP3K5	3.64e-04	257	82	5	30945288
Pubmed	Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism.	UBXN11 PRKAA1 KANK2 ZEB2 TP53BP2 NPAS2	3.84e-04	402	82	6	24722188
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PPRC1 SPHKAP SEC16A KATNIP MED13L ZEB2	4.10e-04	407	82	6	12693553
Pubmed	Dynamic patterns of histone H3 lysine 4 methyltransferases and demethylases during mouse preimplantation development.	KMT2C ASH1L	4.21e-04	13	82	2	24619213
Pubmed	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	DTNB AKAP13	4.21e-04	13	82	2	21844884
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR LIMA1 ZC3H13 SEC16A ATM THOC2 C2CD5 IWS1	4.85e-04	774	82	8	15302935
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	RBSN EEPD1 SEC16A ANKLE2 GOLGB1 C2CD5	4.90e-04	421	82	6	36976175
Pubmed	Genome-wide association study identifies three new melanoma susceptibility loci.	ASIP ATM	4.91e-04	14	82	2	21983787
Pubmed	Functional proteomics mapping of a human signaling pathway.	UBXN11 DROSHA ASH1L ANKLE2 ZEB2 GOLGB1 TP53BP2	4.99e-04	591	82	7	15231748
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	PRUNE2 MAP1A AKAP13 ATM NEK9 TP53BP2	5.47e-04	430	82	6	35044719
Pubmed	A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.	ASIP HAX1 MED13L PHIP C2CD5 FAM111B	5.54e-04	431	82	6	33660365
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	LIMA1 CENPF PPRC1 DTNB ASH1L NAV2 CHD2 ATM ANKLE2 ZEB2 GOLGB1	5.63e-04	1442	82	11	35575683
Pubmed	Antagonistic functions of Dishevelleds regulate Frizzled3 endocytosis via filopodia tips in Wnt-mediated growth cone guidance.	CELSR3 L1CAM	6.45e-04	16	82	2	24305805
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	TBC1D8 ZC3H13 PIEZO1 AKAP13 ATM HAX1 PPP6R2 ANKLE2 KANK2 GOLGB1 C2CD5	7.26e-04	1487	82	11	33957083
Pubmed	Vangl2 promotes Wnt/planar cell polarity-like signaling by antagonizing Dvl1-mediated feedback inhibition in growth cone guidance.	CELSR3 L1CAM	7.30e-04	17	82	2	21316586
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	MAP1A NEK9 GOLGB1	7.84e-04	76	82	3	27542412
Pubmed	Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.	L1CAM HAX1	8.20e-04	18	82	2	35762573
Pubmed	Hirschsprung Disease Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	L1CAM ZEB2	8.20e-04	18	82	2	20301612
Pubmed	Effect of expression alteration in flanking genes on phenotypes of St8sia2-deficient mice.	AKAP13 CHD2	8.20e-04	18	82	2	31541165
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	TBC1D8 BMPR2 DTNB SEC16A ARFGEF1 ATM HAX1 NEK9 GOLGB1	8.83e-04	1061	82	9	33845483
Pubmed	Collagen VI suppresses fibronectin-induced enteric neural crest cell migration by downregulation of focal adhesion proteins.	L1CAM ZEB2	9.15e-04	19	82	2	29196262
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MAP1A SEC16A ANKLE2 ZEB2	9.61e-04	184	82	4	32908313
Pubmed	Recruitment of the human TREX complex to mRNA during splicing.	ZC3H13 THOC2	1.01e-03	20	82	2	15998806
Pubmed	Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	KMT2C HAX1	1.01e-03	20	82	2	29785026
Pubmed	Adiponectin enhances mouse fetal fat deposition.	PRKAA1 NR1H3	1.01e-03	20	82	2	22872236
Pubmed	A distinct response to endogenous DNA damage in the development of Nbs1-deficient cortical neurons.	ATM TP53BP2	1.01e-03	20	82	2	22212482
Pubmed	Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.	LIMA1 ZC3H13 AKAP13 TP53BP2	1.08e-03	190	82	4	15161933
Pubmed	Mendelian randomization and experimental IUGR reveal the adverse effect of low birth weight on lung structure and function.	BMPR2 PRKAA1	1.12e-03	21	82	2	33372189
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	DTNB PRKAA1 CHD2 HAX1 PPP6R2 KANK2 NEK9 C2CD5	1.38e-03	910	82	8	36736316
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	BMPR2 MAP1A L1CAM PPP6R2 C2CD5	1.40e-03	347	82	5	17114649
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ZXDC KMT2C RBSN HOXC10 IGHMBP2 NR1H3 PHIP	1.44e-03	709	82	7	22988430
Pubmed	Sucrose non-fermenting related kinase enzyme is essential for cardiac metabolism.	MAP1A PRKAA1	1.47e-03	24	82	2	25505152
Pubmed	Reduced endothelin converting enzyme-1 and endothelin-3 mRNA in the developing bowel of male mice may increase expressivity and penetrance of Hirschsprung disease-like distal intestinal aganglionosis.	L1CAM ZEB2	1.47e-03	24	82	2	17131407
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	KMT2C CHD2 THOC2 GOLGB1	1.51e-03	208	82	4	33230847
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KMT2C CELSR3 PIEZO1 HPS4 NAV2 ANKLE2	1.59e-03	529	82	6	14621295
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	TPR LIMA1 SEC16A MAP4K2 GOLGB1	1.64e-03	360	82	5	33111431
Pubmed	Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy.	SEC16A NEK9	1.72e-03	26	82	2	24067654
Pubmed	MRNIP interacts with sex body chromatin to support meiotic progression, spermatogenesis, and male fertility in mice.	MRNIP ATM	1.72e-03	26	82	2	35920200
Pubmed	N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation.	ZXDC KMT2C RBSN AKAP13	1.76e-03	217	82	4	34048709
Pubmed	Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ASTN2 PPP6R2 ANKLE2	1.83e-03	102	82	3	9734811
Pubmed	Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef.	LCP2 MAP3K5	1.86e-03	27	82	2	22844345
Pubmed	Same but different - Molecular comparison of human KTI12 and PSTK.	RBSN ANKLE2	1.86e-03	27	82	2	33417976
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	PRUNE2 ZC3H13 ASH1L ASTN2 AKAP13 THOC2 GOLGB1	5.64e-06	221	81	7	M39222
Coexpression	MURARO_PANCREAS_BETA_CELL	PRUNE2 PIM3 KMT2C MAP1A HPS4 ASH1L PIPOX NAV2 MSANTD4 HAX1 GOLGB1 C2CD5 COPS7A	6.28e-06	946	81	13	M39169
Coexpression	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN	ZC3H13 LAIR1 GCH1 HAX1 MAP3K5 COPS7A	3.59e-05	199	81	6	M9943
Coexpression	GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	KMT2C L1CAM AKAP13 CHD2 MAP4K2 MAP3K5	3.69e-05	200	81	6	M6477
Coexpression	GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN	LAIR1 MRNIP NR1H3 PIWIL2 MED13L IWS1	3.69e-05	200	81	6	M5808
Coexpression	GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP	ZXDC BMPR2 HPS4 KATNIP GOLGB1 MAP3K5	3.69e-05	200	81	6	M6623
Coexpression	GSE3982_MAST_CELL_VS_TH2_DN	TPR SGSH PIEZO1 PIWIL2 PPP6R2 MAP4K2	3.69e-05	200	81	6	M5456
Coexpression	LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM	PRUNE2 ZC3H13 ASTN2 AKAP13 CHD2 THOC2 PPP6R2 GOLGB1	4.48e-05	417	81	8	M39224
Coexpression	GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN	L1CAM CIAO2B GCH1 MED13L NPAS2	1.14e-04	153	81	5	M350
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	THEMIS2 PPRC1 AKAP13 MAP4K2 MAP3K5	1.32e-04	158	81	5	M9147
Coexpression	LAKE_ADULT_KIDNEY_C28_INTERSTITIUM	NAV2 MED13L ZEB2 MAP3K5	1.48e-04	86	81	4	M39247
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	TPR KMT2C TC2N PIEZO1 ASH1L LAIR1 AKAP13 CHD2 ATM LCP2 ANKLE2 NEK9 PHIP ZEB2	1.77e-04	1492	81	14	M40023
Coexpression	GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_DN	TBC1D8 LIMA1 DPCD ANKLE2 NPAS2	2.30e-04	178	81	5	M6728
Coexpression	TRAVAGLINI_LUNG_NONCLASSICAL_MONOCYTE_CELL	THEMIS2 TBC1D8 GCH1 NFAM1 ZEB2	2.43e-04	180	81	5	M41701
Coexpression	GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP	THEMIS2 DPCD L1CAM LAIR1 ZEB2	2.43e-04	180	81	5	M2941
Coexpression	GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	THEMIS2 DPCD L1CAM LAIR1 ZEB2	2.49e-04	181	81	5	M7006
Coexpression	GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	SEC16A CHD2 ATM THOC2 NEK9	2.69e-04	184	81	5	M9005
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	THEMIS2 PRUNE2 DROSHA ZC3H13 PIPOX NAV2 ASTN2 CHD2 MED13L KANK2 ZEB2	2.69e-04	1009	81	11	M157
Coexpression	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	CENPF DROSHA NAV2 KANK2	2.86e-04	102	81	4	M2124
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	CENPF ARFGEF1 AKAP13 MED13L THOC2 ANKLE2 PHIP ZEB2 TP53BP2 C2CD5	3.03e-04	856	81	10	M4500
Coexpression	HEVNER_CORTEX_COMMITTED_TO_SUBCEREBRAL_PROJECTION_NEURON_FATE	SPHKAP L1CAM	3.35e-04	9	81	2	MM429
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	CENPF PPRC1 MED13L PHIP MAP3K5 NPAS2	3.38e-04	300	81	6	M8702
Coexpression	GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN	THEMIS2 AKAP13 ATM MED13L ZEB2	3.43e-04	194	81	5	M7306
Coexpression	GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP	TC2N AKAP13 ATM MED13L GOLGB1	3.51e-04	195	81	5	M7397
Coexpression	GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN	IQCC AKAP13 ATM HAX1 MAP4K2	3.76e-04	198	81	5	M5571
Coexpression	GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_UP	THEMIS2 KMT2C CIAO2B DELE1 MAP3K5	3.85e-04	199	81	5	M8964
Coexpression	GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	ZC3H13 MED13L LCP2 ZEB2 NPAS2	3.85e-04	199	81	5	M8381
Coexpression	GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN	KMT2C PPRC1 AKAP13 ANKLE2 ZEB2	3.85e-04	199	81	5	M3517
Coexpression	GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP	THEMIS2 PIEZO1 MRNIP CHD2 MAP4K2	3.85e-04	199	81	5	M8318
Coexpression	GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP	MISP BMPR2 CELSR3 TP53BP2 NPAS2	3.85e-04	199	81	5	M8371
Coexpression	GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN	DTNB PRKAA1 HAX1 NEK9 TP53BP2	3.85e-04	199	81	5	M8415
Coexpression	GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN	THEMIS2 ZNF8 PIEZO1 CHD2 MAP4K2	3.85e-04	199	81	5	M8289
Coexpression	GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN	TBC1D8 TPR LIMA1 GCH1 ZEB2	3.85e-04	199	81	5	M3731
Coexpression	GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_UP	UBXN11 ZC3H13 PIPOX MED13L LCP2	3.85e-04	199	81	5	M3073
Coexpression	GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP	HOXC10 HPS4 NR1H3 CHD2 TP53BP2	3.94e-04	200	81	5	M9391
Coexpression	GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP	PRUNE2 SGSH DELE1 NFAM1 NEK9	3.94e-04	200	81	5	M3507
Coexpression	GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN	TPR KMT2C NPY5R ARFGEF1 AKAP13	3.94e-04	200	81	5	M3510
Coexpression	GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP	PIM3 SGSH DPCD LAIR1 ARFGEF1	3.94e-04	200	81	5	M4841
Coexpression	GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN	CEP20 CENPF MRNIP C8orf48 HAX1	3.94e-04	200	81	5	M6540
Coexpression	GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN	L1CAM AKAP13 LCP2 NFAM1 MAP3K5	3.94e-04	200	81	5	M8486
Coexpression	GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN	LAIR1 GCH1 LCP2 TP53BP2 IWS1	3.94e-04	200	81	5	M7502
CoexpressionAtlas	Myeloid Cells, Mo.6C-IIint.Bl, CD115+ B220- CD43- Ly6C- MHCIIint, Blood, avg-5	THEMIS2 TBC1D8 LIMA1 BMPR2 L1CAM LAIR1 GCH1 NFAM1 ZEB2 MAP3K5	2.87e-06	400	81	10	GSM605886_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	ZC3H13 ASH1L NAV2 CHD2 THOC2 ZEB2	2.36e-05	150	81	6	gudmap_developingGonad_e12.5_epididymis_k5_500
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPR KMT2C ASH1L AKAP13 CHD2 ATM MED13L PHIP ZEB2 GOLGB1	4.98e-12	200	84	10	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	KMT2C ASH1L ARFGEF1 CHD2 MED13L ZEB2 GOLGB1 TP53BP2	2.66e-09	188	84	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMT2C SPHKAP ASH1L SEC16A NAV2 ARFGEF1 GOLGB1	8.81e-08	195	84	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMT2C SPHKAP ASH1L SEC16A NAV2 ARFGEF1 GOLGB1	8.81e-08	195	84	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	KMT2C TC2N ASH1L ARFGEF1 CHD2 ATM	1.72e-06	192	84	6	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	Adult-Immune-monocyte-D231\|Adult / Lineage, Cell type, age group and donor	THEMIS2 TBC1D8 GCH1 LCP2 NFAM1 ZEB2	1.88e-06	195	84	6	ea24da6fea1487acb1e56c28c0649858cc0a12bd
ToppCell	COVID-19-Myeloid-Transitioning_MDM\|COVID-19 / group, cell type (main and fine annotations)	THEMIS2 TBC1D8 EEPD1 LCP2 NFAM1 ZEB2	1.94e-06	196	84	6	4929cfed1f150c1fde4d79cb49895c2ea467a18f
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	PIM3 KMT2C AKAP13 MED13L LCP2 ZEB2	2.06e-06	198	84	6	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TC2N ASH1L ARFGEF1 CHD2 ATM GOLGB1	2.12e-06	199	84	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 UBXN11 LAIR1 LCP2 NFAM1 ZEB2	2.12e-06	199	84	6	1413156b7be5373fd02bbe39ec50ccfe165fa6d1
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	PRUNE2 MAP1A ASPN SPHKAP KANK2 ZEB2	2.18e-06	200	84	6	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MISP IQCC LAIR1 C8orf48 ZEB2	1.16e-05	156	84	5	d72c2f5f72d269e29033f8728d924e0d4c8772c7
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	L1CAM LAIR1 LCP2 NFAM1 MAP3K5	1.31e-05	160	84	5	2020b6defbaf5b5db12af37f0103ac028a8ca76e
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	L1CAM LAIR1 LCP2 NFAM1 MAP3K5	1.31e-05	160	84	5	af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae
ToppCell	facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	L1CAM LAIR1 LCP2 NFAM1 MAP3K5	1.40e-05	162	84	5	3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704
ToppCell	facs-Lung-nan-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	L1CAM LAIR1 LCP2 NFAM1 MAP3K5	1.40e-05	162	84	5	8134f73eb76693f4f1845f643042fdc1e81c274c
ToppCell	droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TBC1D8 LAIR1 NR1H3 LCP2 NFAM1	1.57e-05	166	84	5	1a3a15d1fc76bb91d832cdc6e3da0a6140b94b75
ToppCell	metastatic_Brain-T/NK_cells-Exhausted_Tfh\|T/NK_cells / Location, Cell class and cell subclass	ZXDC LIMA1 UBXN11 CYP2F1 DPCD	2.20e-05	178	84	5	9a3581a0158dfa5a1cc942f8c532afb5e38b272a
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TPR BMPR2 ZC3H13 PRKAA1 IWS1	2.71e-05	186	84	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	NS-moderate-d_0-4-Myeloid-Non-resident_Macrophage\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	2.78e-05	187	84	5	fcc32dbc9c5ae6176f154715a3e73aa32d78ad64
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 SEC16A NAV2 AKAP13 GOLGB1	2.85e-05	188	84	5	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	THEMIS2 TBC1D8 LCP2 NFAM1 ZEB2	2.93e-05	189	84	5	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	2.93e-05	189	84	5	7ccea2df93bb4b37417bbc8f6c85a61ece95211a
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	TBC1D8 AKAP13 THOC2 GOLGB1 MAP3K5	2.93e-05	189	84	5	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	COVID-19-lung-Macrophage_PPARGhi_CD5Lhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	THEMIS2 LAIR1 NR1H3 LCP2 ZEB2	3.16e-05	192	84	5	bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175\|Adult / Lineage, Cell type, age group and donor	EEPD1 LAIR1 NR1H3 LCP2 ZEB2	3.16e-05	192	84	5	733491e932350e3c216a626cc49c3cd3fe970a82
ToppCell	Control-Myeloid-Monocyte-derived_macrophages\|Control / group, cell type (main and fine annotations)	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	3.23e-05	193	84	5	a6b3bd01e585e2e3fbe9bf693a2e385773123f8e
ToppCell	Control-Myeloid-ncMonocyte\|Myeloid / Disease state, Lineage and Cell class	TBC1D8 GCH1 MED13L LCP2 NFAM1	3.23e-05	193	84	5	3479c01aaae7afd7e02d00e0cb21951c0106a0fd
ToppCell	Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	3.32e-05	194	84	5	3043f6230fa723037c8cf7123f611ae847b39fd4
ToppCell	nucseq-Immune-Immune_Myeloid-pMON-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TBC1D8 GCH1 LCP2 NFAM1 ZEB2	3.32e-05	194	84	5	e237384b02be460d44eeada3026a5691c66f6fc1
ToppCell	nucseq-Immune-Immune_Myeloid-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TBC1D8 GCH1 LCP2 NFAM1 ZEB2	3.32e-05	194	84	5	0bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PRUNE2 TPR MAP1A L1CAM GOLGB1	3.32e-05	194	84	5	8985095f291c1b54e45f4edece49aa26e8c8b732
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma\|TCGA-Adrenal / Sample_Type by Project: Shred V9	CELSR3 MAP1A L1CAM ASTN2 GCH1	3.32e-05	194	84	5	b6488bc3a8905e926ad298332963e1bbaf010046
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma\|TCGA-Adrenal / Sample_Type by Project: Shred V9	CELSR3 MAP1A L1CAM ASTN2 GCH1	3.32e-05	194	84	5	1e1f4139ad584f493d75a9b7f1568eca4653c5a2
ToppCell	cellseq-Immune-Immune_Myeloid-pMON-pMON\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	THEMIS2 TBC1D8 GCH1 NFAM1 ZEB2	3.40e-05	195	84	5	2cb435dae2691e1250e26e59f9b8fb652a0c383e
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|lung / Disease (COVID-19 only), tissue and cell type	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	3.40e-05	195	84	5	148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCell	Control-Myeloid-ncMonocyte\|Control / Disease state, Lineage and Cell class	TBC1D8 GCH1 MED13L LCP2 NFAM1	3.40e-05	195	84	5	fcb05948e7480dc53f06f3fc9b9c3fc129874edd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS2 GCH1 LCP2 NFAM1 ZEB2	3.40e-05	195	84	5	10ce1b6961f10372d1f65388cbf3626a5fcd6840
ToppCell	cellseq-Immune-Immune_Myeloid-pMON\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	THEMIS2 TBC1D8 GCH1 NFAM1 ZEB2	3.40e-05	195	84	5	217908cb53016a6cb51f1bc3fc752c8df650df71
ToppCell	Control-Myeloid-ncMonocyte\|World / Disease state, Lineage and Cell class	TBC1D8 GCH1 MED13L LCP2 NFAM1	3.40e-05	195	84	5	b4444b67a709e82b8e2ee510924c3152cb88b051
ToppCell	control-Myeloid-Non-resident_Macrophage\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	3.48e-05	196	84	5	646a8d47dddffdfd2d8a62245ea6cd49f9510a1a
ToppCell	Adult-Immune-monocyte\|Adult / Lineage, Cell type, age group and donor	THEMIS2 TBC1D8 LCP2 NFAM1 ZEB2	3.48e-05	196	84	5	3ef193c5180de3137daf886492e74fc574bc9767
ToppCell	COVID-19-lung-Macrophage_metabolically_active\|lung / Disease (COVID-19 only), tissue and cell type	THEMIS2 LAIR1 NR1H3 LCP2 ZEB2	3.48e-05	196	84	5	a753d76d764c181eecb0e17a794a2e7d0ff70136
ToppCell	COVID-19-lung-Macrophage_metabolically_active\|COVID-19 / Disease (COVID-19 only), tissue and cell type	THEMIS2 LAIR1 NR1H3 LCP2 ZEB2	3.48e-05	196	84	5	1b7928f4eee94d4bb6ea410bab68a471dba12979
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MISP LIMA1 CYP2F1 PPRC1 NAV2	3.57e-05	197	84	5	d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5
ToppCell	mLN-B_cell-B_cell_cycling\|B_cell / Region, Cell class and subclass	LIMA1 PPRC1 DROSHA EEPD1 DPCD	3.57e-05	197	84	5	2071526fe46de8359ea118ff78581eb4454aa55a
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MISP LIMA1 CYP2F1 PPRC1 NAV2	3.57e-05	197	84	5	80b05c8ad9c1edc5dea3236079372475431343fe
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	THEMIS2 GCH1 LCP2 NFAM1 ZEB2	3.57e-05	197	84	5	c6e977adb1248957d31300312310e08238b64236
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	ZC3H13 CHD2 THOC2 PHIP GOLGB1	3.57e-05	197	84	5	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	THEMIS2 GCH1 LCP2 NFAM1 ZEB2	3.65e-05	198	84	5	7015b9f5ead65937e056d746340d44d0655d6a3e
ToppCell	moderate-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	LIMA1 TC2N CYP2F1 ARFGEF1 AKAP13	3.65e-05	198	84	5	7ecce5e266bb08797088cc8f8309e0c7b48df5c9
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	THEMIS2 GCH1 LCP2 NFAM1 ZEB2	3.65e-05	198	84	5	6edf6c547e8a3aa2b23df4662bf59ed38caa9e5e
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	CENPF ZC3H13 SEC16A GOLGB1 IWS1	3.65e-05	198	84	5	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	3.65e-05	198	84	5	623f9d64c9e800d2d7f623392bf2f22b563f0249
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	THEMIS2 GCH1 LCP2 NFAM1 ZEB2	3.74e-05	199	84	5	e12cea071e46436835cc22fe7badcbe878a1305b
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	THEMIS2 GCH1 LCP2 NFAM1 ZEB2	3.74e-05	199	84	5	2ff5007b971c6fca9a9ef433e257739f0322a2a5
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	TPR ZC3H13 THOC2 GOLGB1 IWS1	3.74e-05	199	84	5	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Macrophages-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	THEMIS2 LAIR1 NR1H3 LCP2 ZEB2	3.74e-05	199	84	5	b51bcbe1675b9665e649a6aa96b1a00575a36093
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	TPR LIMA1 ZC3H13 ARFGEF1 GOLGB1	3.74e-05	199	84	5	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 TBC1D8 LCP2 NFAM1 ZEB2	3.74e-05	199	84	5	ac866ae110967c5867ff4601939b79861d43df54
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	3.74e-05	199	84	5	6ce7612ee2ae211eb0f73391e96089ad5431c537
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	TPR LIMA1 ZC3H13 THOC2 GOLGB1	3.74e-05	199	84	5	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	700960201ae0df2c79e2907f5a0f95d73f8034fe
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	179afc4bee7a2fd85a3b5dadf32544a63807c164
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	UBXN11 WDR97 AKAP13 DELE1 NFAM1	3.83e-05	200	84	5	88d713dfc792e7609bf7ecfb28f87cb748088570
ToppCell	Tracheal-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	ad7ae5106141669b353800fece833b3cd5bdccee
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Monocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 TBC1D8 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	fd72fe6565e2f4885481991492d58c323ab1ad40
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	f3dc07a7cc8cf041da8fe610d21af595818cf2d8
ToppCell	Tracheal-10x5prime-Immune_Myeloid\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	fc6aebc20ecaa67606154540a691242dc0aea867
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 TBC1D8 GCH1 NFAM1 ZEB2	3.83e-05	200	84	5	83d9aa5b46ae7a71a258b2e44b3251f95bc9a1b7
ToppCell	Children_(3_yrs)-Immune-monocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	THEMIS2 TBC1D8 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	881ab995c90d75fd987d6e8f1f926a4bfcc4235f
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 TBC1D8 GCH1 NFAM1 ZEB2	3.83e-05	200	84	5	d39bf03817b76c9dfcbcd868341b51bb8601ea9b
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	ad52b38df5c71f28829b04cd0e6b97f0f9f7610a
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 UBXN11 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	5432bdf495431cd26f6e4cd585100f3652588913
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Monocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 UBXN11 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	8872d5fa101d413fb43b4231d476878678543035
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	MAP1A ASPN SPHKAP KANK2 ZEB2	3.83e-05	200	84	5	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	Biopsy_IPF-Immune-Monocytes\|Biopsy_IPF / Sample group, Lineage and Cell type	THEMIS2 GCH1 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	80b2b7eecc5dce9d22f9c80562e4aea83bbf0f50
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	PIM3 KMT2C AKAP13 MED13L GOLGB1	3.83e-05	200	84	5	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 LAIR1 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	46f9c28b24e39acdf0481a02b6eb86ecdd83c504
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	THEMIS2 TBC1D8 LAIR1 AKAP13 NFAM1	3.83e-05	200	84	5	74ceebee9af63f8b3ec5857eff1b662752bc3862
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS2 TBC1D8 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	fc061de0db2e8b5ca47f5e2a1e861018e7f1b582
ToppCell	Biopsy_Other_PF-Immune-Monocytes\|Biopsy_Other_PF / Sample group, Lineage and Cell type	TBC1D8 GCH1 LCP2 NFAM1 ZEB2	3.83e-05	200	84	5	83bca55d48aae8885deb83e15b2684910e4c3358
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	NR1H3 LCP2 NFAM1 ZEB2	8.94e-05	124	84	4	e9b6fdac2bef4bf1fee6a486f4628b68adc80f57
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-2\|TCGA-Brain / Sample_Type by Project: Shred V9	CELSR3 DROSHA L1CAM GPR179	9.81e-05	127	84	4	018ffd9ff1913787cb0086a8581b399a121eaba1
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TBC1D8 ASH1L AKAP13 GOLGB1	1.24e-04	135	84	4	b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell	ASK454-Epithelial-Type_2\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	CENPF ASPN NAV2 KANK2	1.28e-04	136	84	4	ff9a5e111993fdb3ac64c5ef269e3460ff994517
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	ZC3H13 ASH1L GOLGB1 IWS1	1.35e-04	138	84	4	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ASH1L CHD2 ZEB2 GOLGB1	1.72e-04	147	84	4	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Cadm2_(Cadm2+_state)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	MISP LRTM1 PIWIL2	1.89e-04	59	84	3	b2c10c4c0a750d7f49f5a813ab5d103fb07ca76b
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Cadm2_(Cadm2+_state)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	MISP LRTM1 PIWIL2	1.89e-04	59	84	3	bcac768e1e034e27bab7cad3c2bf09a8f0a819ad
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Cadm2_(Cadm2+_state)--\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	MISP LRTM1 PIWIL2	1.89e-04	59	84	3	f9b9464f4d786991aad01b47e2a8fd33f889c2e2
ToppCell	droplet-Lung-nan-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	L1CAM LAIR1 LCP2 NFAM1	2.01e-04	153	84	4	6dcab3d50ab50051955204dc4e4a64c1ca855bcd
ToppCell	droplet-Lung-nan-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	L1CAM LAIR1 LCP2 NFAM1	2.01e-04	153	84	4	f6ef14d949107c08cb3690e26ec91e194cb43518
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHD2 LCP2 NFAM1 ZEB2	2.11e-04	155	84	4	77ae0b8d30bc3db4a73fd5340f99691a73d2684f
ToppCell	facs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	L1CAM LAIR1 NFAM1 MAP3K5	2.22e-04	157	84	4	0ad242320ada7bcb9e29548d3050bf4fd3a07115
ToppCell	facs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	L1CAM LAIR1 NFAM1 MAP3K5	2.22e-04	157	84	4	fe4c9556806203e57522d1986754ebe5a20aa2de
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MAP1A CENPF C8orf48 KANK2	2.22e-04	157	84	4	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	droplet-Liver-Hepatocytes-18m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MISP IQCC NR1H3 C8orf48	2.27e-04	158	84	4	d3446fc98eff09c3626b47a2c90d07cd985378b5
ToppCell	facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	L1CAM LAIR1 LCP2 NFAM1	2.27e-04	158	84	4	121d63b8e2e37107467b170e5b2c798a7dbf6325
ToppCell	droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MISP IQCC NR1H3 C8orf48	2.27e-04	158	84	4	df614450e10629dc9115d7365397663e82f9e48f
Drug	Thiethylperazine malate [52239-63-1]; Down 200; 6uM; MCF7; HT_HG-U133A	ZNF8 ZXDC CENPF IGHMBP2 ARFGEF1 ATM PPP6R2	7.17e-06	197	82	7	6232_DN
Drug	Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A	THEMIS2 CELSR3 MAP1A DTNB IGHMBP2 ASTN2 MAP3K5	7.41e-06	198	82	7	7501_DN
Disease	reticulocyte measurement	TBC1D8 BMPR2 DTNB PIEZO1 EEPD1 PRKAA1 ASH1L AKAP13 KANK2 ZEB2 MAP3K5	9.91e-05	1053	78	11	EFO_0010700
Disease	cerebral infarction (implicated_via_orthology)	GCH1 MAP3K5	1.03e-04	6	78	2	DOID:3526 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	KMT2C ASH1L CHD2 MED13L	1.10e-04	93	78	4	C1535926
Disease	cutaneous melanoma	DTNB ASIP ATM MED13L	3.04e-04	121	78	4	EFO_0000389
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	L1CAM AKAP13 ATM FAM111B	6.50e-04	148	78	4	C0279702
Disease	vitamin K-dependent protein C measurement	ASIP TEX51	7.08e-04	15	78	2	EFO_0008318
Disease	hydrocephalus (implicated_via_orthology)	DPCD L1CAM	1.15e-03	19	78	2	DOID:10908 (implicated_via_orthology)
Disease	leukemia (implicated_via_orthology)	ASH1L ATM	1.15e-03	19	78	2	DOID:1240 (implicated_via_orthology)
Disease	depressive symptom measurement, response to antidepressant	CEP20 PIEZO1 GOLGB1	1.66e-03	88	78	3	EFO_0007006, GO_0036276
Disease	Huntington's disease (is_implicated_in)	PRKAA1 MAP3K5	1.68e-03	23	78	2	DOID:12858 (is_implicated_in)
Disease	gastric carcinoma	UNC5CL PRKAA1 ASH1L	1.71e-03	89	78	3	EFO_0000178
Disease	nevus count, cutaneous melanoma	DTNB ATM MED13L	1.83e-03	91	78	3	EFO_0000389, EFO_0004632
Disease	Malignant neoplasm of breast	THEMIS2 BMPR2 CENPF PRKAA1 ASTN2 ATM ZEB2 GOLGB1 TP53BP2	2.08e-03	1074	78	9	C0006142
Disease	monocyte count	THEMIS2 UBXN11 PIEZO1 ZNF408 ASH1L AKAP13 ATM HAX1 MED13L MAP3K5	2.46e-03	1320	78	10	EFO_0005091
Disease	mean corpuscular hemoglobin concentration	BMPR2 PIEZO1 PRKAA1 SEC16A AKAP13 GCH1 HAX1 ZEB2 GOLGB1	2.52e-03	1105	78	9	EFO_0004528
Disease	obesity (implicated_via_orthology)	ASIP PRKAA1 SEC16A MED13L	2.57e-03	215	78	4	DOID:9970 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
SSPRHEDQLEVTREP	ANKLE2	806	Q86XL3
QLQDPDDLDDSHRPS	ASH1L	941	Q9NR48
TSQDPEQHLTELREP	COPS7A	231	Q9UBW8
DIHDSIQPRSVDNRP	ARFGEF1	1571	Q9Y6D6
NSNEPDTRPLEDRAV	AKAP13	831	Q12802
LDDDREPRPSLSHEN	CEP20	36	Q96NB1
EPRPSLSHENLLINE	CEP20	41	Q96NB1
PSSLRRDLLAEQQPH	EEPD1	111	Q7L9B9
DEDNSLFPTREPRSH	ASPN	51	Q9BXN1
ENHENERIPRPLSPT	TP53BP2	686	Q13625
EEDEEPPRRANHVSR	ASTN2	296	O75129
NSHLPPEEKLRDDRS	ASIP	21	P42127
SEEDEHPQQRLSSPL	RBSN	691	Q9H1K0
DHQASLDPRSPRDFI	CYP2F1	251	P24903
RHQASDSENEELPKP	IWS1	231	Q96ST2
RISDSESEDPPRHQA	IWS1	246	Q96ST2
PRHQASDSENEELPK	IWS1	256	Q96ST2
TRMENPEATDQRLPH	IQCC	141	Q4KMZ1
HRDIILESIPTDNPE	MAP4K2	791	Q12851
RQEEEQAHATSLPPR	NR1H3	181	Q13133
HVDSEQPRSLQRDPR	MRNIP	241	Q6NTE8
RQELALEDPPSEALH	NPAS2	361	Q99743
EAHQDFPRLSDDPRI	C8orf48	246	Q96LL4
QPSPRGLHSENREDE	MISP	76	Q8IVT2
RPPENHNAGERELLE	LRTM1	256	Q9HBL6
DPHPRTREDNDLDSQ	HAX1	176	O00165
VLQTPPDIQSEHSRD	KMT2C	1216	Q8NEZ4
DEQEVPLREHATRSP	MAP1A	1736	P78559
TDELLPARNSQRVPH	MED13L	2141	Q71F56
ERPAQLANARETPHS	LIMA1	476	Q9UHB6
QDPEQRPTADELLDR	NEK9	291	Q8TD19
ADSVSHLDRQRPDQP	GPR179	1966	Q6PRD1
HQISASPRDLNELPE	KATNIP	1246	O60303
AQTIHTQEEDLPRPS	LAIR1	16	Q6GTX8
HRTAPQEQRLPTGED	HPS4	216	Q9NQG7
RDPELRTHNLTDLSP	L1CAM	971	P32004
QQRPEDETELHPTLN	ATM	2971	Q13315
EQSLDPPIEEEHQLR	CENPF	2286	P49454
SPLDHRSPLERSLEQ	CHD2	1801	O14647
SIPDLDRHQLPLDDA	DPCD	141	Q9BVM2
TRLNINSSPDEHEPL	BMPR2	856	Q13873
NSSPDEHEPLLRREQ	BMPR2	861	Q13873
RLRLEHEQASQPTPE	DTNB	456	O60941
QRASLNPRAEHLESP	HOXC10	176	Q9NYD6
EPTHREPTRQAASQE	KANK2	451	Q63ZY3
LALSAESHRPPELQD	C1orf127	631	Q8N9H9
REQLDQVPSRHPSRE	CELSR3	3201	Q9NYQ7
DVEHSREQILPPQDL	FAM111B	316	Q6SJ93
HDENDPRVREQPRGT	FAM27D1	151	Q5T7N8
REPLDHRTSSEQADP	PPRC1	1351	Q5VV67
LDRIHNPDEPETRDA	C2CD5	376	Q86YS7
RSINDPEHPLTLEEL	CIAO2B	51	Q9Y3D0
HNSLRGARPQDPSEE	DELE1	176	Q14154
RVEPPHENGNRSLET	PPP6R2	416	O75170
DDHEEQPSNQTVRRP	MAP3K5	1196	Q99683
DPTPSRINHNERLEF	DROSHA	956	Q9NRR4
HEDTRNALPPRQDGE	SPHKAP	371	Q2M3C7
EPPNSLDLNDTHPRR	PRUNE2	2786	Q8WUY3
QPRTQETPSHLEELE	TC2N	86	Q8N9U0
EEDQPLLIHRPSERQ	PIWIL2	466	Q8TC59
ERPSQENHSRILPEN	NPY5R	301	Q15761
QSPLSQERPHRFEDD	NFAM1	246	Q8NET5
ERPRSEEDNELNLPN	GCH1	56	P30793
LPRKQDSDPHLDRNT	NAV2	1496	Q8IVL1
DSNPTLEPSLEVHRL	REELD1	266	A0A1B0GV85
RSRDPHETQNLATDP	SGSH	441	P51688
SRRENELPDFPHIDE	MSANTD4	171	Q8NCY6
GPPTELSQNRDHLEE	TEX51	41	A0A1B0GUA7
ETPRARHTLDELNPQ	PRKAA1	381	Q13131
HSRRQDLLPQLEAPS	ZXDC	476	Q2QGD7
RKRDHSNNDREVPPD	THOC2	1481	Q8NI27
PEDLEQNNVHPIRDE	PHIP	1671	Q8WWQ0
QERRHLLQEARSPDP	SEC16A	2011	O15027
QERHLEQRDEPQEPS	TPR	1621	P12270
EQRGPDQPDLRTLHL	IGHMBP2	821	P38935
DSPRLDHRPQDDPTD	WDR97	676	A6NE52
ENDRDSQSPLRNPLL	TBC1D8	931	O95759
PQLLDTHREEEVSPA	ZNF408	656	Q9H9D4
RPAKPQRQDLDDDEH	THEMIS2	616	Q5TEJ8
ENEVSRQHLPATLPE	UNC5CL	61	Q8IV45
LRPSERPSLDQIAAH	PIM3	276	Q86V86
DPPLSQDERTHRSDR	ZNF8	451	P17098
NHADPEERDCPTART	PIPOX	276	Q9P0Z9
TRQSPHPRELDDDER	PIEZO1	146	Q92508
SPHVSQALLPREEEE	ZEB2	71	O60315
PSSPIRHQGRNDELE	ZC3H13	641	Q5T200
PHPAEATLQRQEELE	UBXN11	116	Q5T124
HRKSDPEELREPQQS	GOLGB1	3121	Q14789
RRENDEDDVHQRPLP	LCP2	316	Q13094